Related Experiment Video
Updated: Jun 15, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Noninferiority trial design and analysis with an ordered three-level categorical endpoint
1Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA. ebrittain@niaid.nih.gov
Journal of Biopharmaceutical Statistics
|February 26, 2010
Summary
This study introduces a new method for noninferiority trial design using a three-level ordered endpoint. It presents sample size calculations and compares this approach to traditional binary endpoints for clinical trial planning.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Methodology
Background:
- Standard noninferiority trial designs typically use binary endpoints.
- Extending these designs to ordered, multi-level outcomes is crucial for capturing nuanced results.
- Existing methods may not fully leverage information from ordered categorical data.
Purpose of the Study:
- To extend noninferiority trial design methodology to accommodate ordered three-level endpoints.
- To propose a metric for summarizing outcomes on such endpoints and present sample size requirements.
- To compare the proposed three-level endpoint approach with collapsed binary endpoints.
Main Methods:
- Developed a novel metric to summarize outcomes for an ordered three-level endpoint (e.g., success, intermediate, failure).
- Derived sample size requirements for noninferiority trials using this metric.
- Analyzed the implications of collapsing the three-level endpoint into two distinct binary endpoints.
- Compared noninferiority margins and sample size needs between the three-level and binary approaches.
Main Results:
- A metric for ordered three-level endpoints in noninferiority trials was proposed.
- Sample size requirements for this new methodology were calculated.
- The study identified differences in noninferiority margins and sample size needs when comparing the three-level endpoint to collapsed binary endpoints.
Conclusions:
- The proposed methodology offers a more informative approach to noninferiority trials with ordered outcomes.
- Using a three-level endpoint can provide a more precise assessment compared to collapsing data into binary outcomes.
- This work provides guidance on selecting appropriate endpoints and sample sizes for complex trial designs.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Friedman Two-way Analysis of Variance by Ranks
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures from...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:19The Mantel-Cox Log-Rank Test
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
00:55Ordinal Level of Measurement
The way a set of data is measured is called its level of measurement. Correct statistical procedures depend on a researcher being familiar with levels of measurement. For analysis, data are classified into four levels of measurement—nominal, ordinal, interval, and ratio.
Data measured using an ordinal scale are similar to nominal scale data, but there is one major difference. The ordinal scale data can be ordered. An example of ordinal scale data is a list of the top five national parks in the...
Data measured using an ordinal scale are similar to nominal scale data, but there is one major difference. The ordinal scale data can be ordered. An example of ordinal scale data is a list of the top five national parks in the...